Biotech Firms Join IPO Wave After Raising $561M Combined
Radiopharmaceutical-drug maker RayzeBio Inc. and brain disease-focused Neumora Therapeutics Inc. began trading Friday with varying results after pricing initial public offerings that raised a combined $561 million, joining a rebounding IPO...To view the full article, register now.
Already a subscriber? Click here to view full article